AI-Powered Biomarker discovery: Precision Diagnostics in Organ Transplant Risk Assessment

2025 AI in Drug Discovery: Predictions

As AI continues to transform the pharmaceutical landscape, 2025 is set to bring significant advancements in drug discovery. Our scientific team has explored the latest trends and developments, identifying three key predictions that could redefine the field this year....
Data Bytes: How can biomarkers de-risk drug development?

Data Bytes: How can biomarkers de-risk drug development?

Biomarkers can play a crucial role in de-risking drug development by providing measurable indicators of biological processes associated with disease onset, progression, and treatment response. In this episode of Data Bytes, we spoke with Dr Alexander Koch, Team Lead...